InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,702.55
(
-0.19%
)
US TECH 100
19,287.60
(
-0.24%
)
Dow Jones
42,063.36
(
0.09%
)
Brent Oil
74.14
(
0.00%
)
Bitcoin
63,288.03
(
-0.14%
)
Post# of 43362
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

ohm20

Send PM Follow Ignore
Followers 46
Posts 2450
Boards Moderated 0
Alias Born 04/17/2019

ohm20

Re: nelskof post# 22893

Tuesday, 12/15/2020 4:27:15 PM

Tuesday, December 15, 2020 4:27:15 PM

Post# of 43362
Did you want me to look at the one that most closely resembles the primary endpoint of the phase 3 trial? That doesn't look good.

Incidence of clinical improvement lenzilumab group - 11 (92%) control group 22 (81%) p = .43
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up